Treatment for cough

Details Treatment for cough Treatment for cough

2005-12-13

2005-12-13

Krass, Frederick (Department: 1614)

Drug, bio-affecting and body treating compositions

Effervescent or pressurized fluid containing

Organic pressurized fluid

C514S654000, C514S665000, C514S666000

Reexamination Certificate

active

06974568

ABSTRACT:
The invention discloses the existence of cannabinoid receptors in the airways, which are functionally linked to inhibition of cough. Locally acting cannabinoid agents can be administered to the airways of a subject to ameliorate cough, without causing the psychoactive effects characteristic of systemically administered cannabinoids. In addition, locally or systemically administered cannabinoid inactivation inhibitors can also be used to ameliorate cough. The present invention also defines conditions under which cannabinoid agents can be administered to produce anti-tussive effects devoid of bronchial constriction.

REFERENCES:
patent: 4464378 (1984-08-01), Hussain
patent: 5596106 (1997-01-01), Cullinan et al.
patent: 5618955 (1997-04-01), Mechoulam et al.
patent: 5631297 (1997-05-01), Pate et al.
patent: 5635530 (1997-06-01), Mechoulam et al.
patent: 5747524 (1998-05-01), Cullinan et al.
patent: 5925672 (1999-07-01), Piomelli et al.
patent: 5977180 (1999-11-01), Pate et al.
patent: 5990170 (1999-11-01), Della Valle et al.
patent: 6013648 (2000-01-01), Rinaldi et al.
patent: 6017919 (2000-01-01), Inaba et al.
patent: 6028084 (2000-02-01), Barth et al.
patent: 6359010 (2002-03-01), Geracioti, Jr. et al.
patent: 0 570 920 (1993-11-01), None
patent: WO 94/12466 (1994-06-01), None
patent: WO 99/60987 (1999-12-01), None
patent: WO 99/64389 (1999-12-01), None
Stengel et al. Pulmonary actions of anandamide, an endogenous cannabinoid receptor agonist in guinea pigs, European Jouna of Pharmacology, vol. 355 (1998) pp. 57-66.
British Medical Association: Therapeutic Uses of Cannabis, Amsterdam harwood acadmeic publishers 1997, excerpt provided.
Seltzman, H., “Structure and receptor activity for classical cannabinoids” Curr Med Chem. 6(8):685-704 (1999).
Shamsuddin et al., Database Medline on STN, Accession No. 1998082798, “Regulation of leukotriene and platelet-activating factor synthesis in human alveolar macrophages”,J. Lab. and Clin. Med., Dec. 1997, vol. 130, No. 6, pp. 615-626.
Stengel et al., “Pulmonary actions of anandamide, an endogenous cannabinoid receptor agonist, in guinia pigs,”European Journal of Pharmacology, Jan. 1998, vol. 355, pp. 57-66.
Zhu et al., “Cytosolic Phospholipase A2 Activation is Essential for beta 1 and beta 2 Integrin-Dependent Adhesion of Human Eosinophils,”Journal of Immunology, Jul. 1999, vol. 163, No. 6, pp. 3423-3429.
Sugiura et al., “2-Archidonoylglycerol and the cannabinoid receptors,”Chemistry and Physics Lipids, Jun. 2000, vol. 108, No. 1-2, pp. 89-106.
De Petrocellis et al., “Endocannabinoids and fatty acid amides in cancer, inflammation and related disorders,”Chemistry and Physics of Lipids, 108 (2000) pp. 191-209.
Gordon et al., “Antitussive Activity of Some Naturally Occurring Cannabinoids in Anesthetized Cats,”European Journal of Pharmacology, 35 (1976) pp. 309-313.
Zou, G., “Endogenous cannabinoid system,”Life Sciences, vol. 9, No. 5, pp. 197-199, Oct. 1997, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 200031.

Affiliated with

Also associated with

Rating

Treatment for cough does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment for cough, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment for cough will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3517195